Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynavox Group ABTDVXF 84 9-Day RSI is 50.90 as of Jul. 26, 2026. GuruFocus rates TDVXF with a GF Score™ of 84/100 and a GF Value™ of $8.46 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 865 Medical Devices & Instruments companies, Dynavox Group AB ranks worse than 93.41% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-26), Dynavox Group AB's 9-Day RSI is 50.90.
The industry rank for Dynavox Group AB's 9-Day RSI or its related term are showing as below:
TDVXF's 9-Day RSI is ranked worse than 93.41% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: 43.08
vs TDVXF: 50.90
Dynavox Group AB (OTCPK:TDVXF) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Dynavox Group AB 9-Day RSI Related Terms
TDVXF vs ISRG, BDX, MDLN: 9-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Dynavox Group AB's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynavox Group AB 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynavox Group AB's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Dynavox Group AB's 9-Day RSI falls into.
Dynavox Group AB (OTCPK:TDVXF) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynavox Group AB (TDVXF) has a 9-Day RSI of 50.90 as of Jul. 26, 2026. According to the industry distribution chart, Dynavox Group AB ranks #808 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 93.4%.
Is Dynavox Group AB's 9-Day RSI too high?
Dynavox Group AB's current 9-Day RSI is 50.90. The Medical Devices & Instruments industry median 9-Day RSI is 43.08. Dynavox Group AB's value of 50.90 is 18.2% above this industry median. Based on the distribution chart, Dynavox Group AB ranks #808 out of 865 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Dynavox Group AB has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynavox Group AB's 9-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dynavox Group AB ranks #808 out of 865 companies for 9-Day RSI. This places Dynavox Group AB in the lower half of its industry. The industry median 9-Day RSI is 43.08. Dynavox Group AB's value of 50.90 is 18.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 43.08, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynavox Group AB's current 9-Day RSI of 50.90 is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 43.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynavox Group AB's current 9-Day RSI is 50.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynavox Group AB stock overvalued right now?
Based on GuruFocus' analysis, Dynavox Group AB (TDVXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.46, compared to a current price of $6.65 — trading 21.4% below its estimated fair value. The current 9-Day RSI is 50.90 and 18.2% above the Medical Devices & Instruments industry median of 43.08. Dynavox Group AB's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Dynavox Group AB (TDVXF), the current 9-Day RSI is 50.90 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynavox Group AB (TDVXF) Overvalued in 2026?
Based on GuruFocus' analysis, Dynavox Group AB stock appears to be undervalued.
The current stock price of $6.65 is trading 21.4% below its estimated GF Value™ of $8.46.
GuruFocus considers Dynavox Group AB to be Modestly Undervalued.
Key valuation signals for TDVXF:
9-Day RSI: 50.90
GF Value™: $8.46 vs. price of $6.65 (21.4% below fair value)
Industry Position: 18.2% above the Medical Devices & Instruments median (#808 of 865)
No single metric tells the full story. See the TDVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
84GF Score
Get the complete analysis for TDVXF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDVXF has been successfully added to your 
